Drawing for BEYOND CANCER

USPTO serial 90295391

BEYOND CANCER

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
THOMA, GABRIELLE M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BEYOND CANCER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laura J. Winston

Laura J. Winston Offit Kurman, P.A.590 Madison Ave., 6th FloorNew York, NY 10022United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and articles, namely, medical gas being nitric oxide for medical purpose to be used at home or in a hospital; gases for medical purposes, namely, nitric oxide for medical purposes; chemical preparations for medical purposes, namely, for chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; chemical preparations for pharmaceutical purposes, namely, for chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; Pharmaceutical preparation for chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; Medical preparation for chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacteriumACTIVE—
010Medical apparatus and instruments, namely, device for the delivery of medical gas to be used at home or in a hospital; Diagnostic, examination, and monitoring equipment, namely, medical and medicine diagnostic systems, detection systems, and monitoring systems for chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium and delivery systems of nitric oxide for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes, namely, medical and therapeutic gas delivery systems; apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patientsACTIVE—
042Scientific research for medical purposes in the area of respiratory diseases; medical research services, namely, conducting clinical trials for others; scientific research, namely, research on the use of nitric oxide for medical purposes; Scientific research, namely, research on preparations and treatments for respiratory diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 29, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 29, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 4, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 3, 2024EX5GSOU EXTENSION 5 GRANTED—
Jan 2, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 8, 2023EXT5SOU EXTENSION 5 FILED—
Dec 8, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 6, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Dec 6, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 6, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 6, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 6, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 6, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 30, 2023DOCKASSIGNED TO EXAMINER—
Jul 7, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 7, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 7, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 7, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 7, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 7, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 24, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 22, 2023EX4GSOU EXTENSION 4 GRANTED—
Jun 22, 2023EXT4SOU EXTENSION 4 FILED—
Jun 22, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 24, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 22, 2022EX3GSOU EXTENSION 3 GRANTED—
Dec 22, 2022EXT3SOU EXTENSION 3 FILED—
Dec 22, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 24, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 22, 2022EX2GSOU EXTENSION 2 GRANTED—
Jun 22, 2022EXT2SOU EXTENSION 2 FILED—
Jun 22, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 24, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 22, 2021EX1GSOU EXTENSION 1 GRANTED—
Dec 22, 2021EXT1SOU EXTENSION 1 FILED—
Dec 22, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 22, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 27, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 27, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 7, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 23, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 23, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Mar 23, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 23, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 23, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 14, 2021DOCKASSIGNED TO EXAMINER—
Dec 31, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 6, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance